Innospec Inc. (NASDAQ:IOSP) Shares Sold by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System decreased its stake in shares of Innospec Inc. (NASDAQ:IOSPFree Report) by 1.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,037 shares of the specialty chemicals company’s stock after selling 122 shares during the period. Maryland State Retirement & Pension System’s holdings in Innospec were worth $1,114,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. GAMMA Investing LLC bought a new position in Innospec during the 4th quarter worth approximately $44,000. Tocqueville Asset Management L.P. acquired a new position in shares of Innospec in the 3rd quarter valued at about $203,000. Stonegate Investment Group LLC acquired a new stake in Innospec during the fourth quarter worth about $204,000. Evergreen Capital Management LLC lifted its holdings in Innospec by 10.2% in the third quarter. Evergreen Capital Management LLC now owns 2,210 shares of the specialty chemicals company’s stock worth $226,000 after acquiring an additional 205 shares during the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in Innospec by 5.4% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,960 shares of the specialty chemicals company’s stock valued at $242,000 after acquiring an additional 100 shares during the period. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, VP Philip John Boon sold 3,715 shares of the stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $122.07, for a total value of $453,490.05. Following the completion of the transaction, the vice president now directly owns 18,516 shares of the company’s stock, valued at approximately $2,260,248.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Innospec news, VP Philip John Boon sold 3,715 shares of the business’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $122.07, for a total transaction of $453,490.05. Following the completion of the transaction, the vice president now owns 18,516 shares in the company, valued at approximately $2,260,248.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Patrick Williams sold 9,667 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $124.37, for a total value of $1,202,284.79. Following the transaction, the chief executive officer now directly owns 174,334 shares in the company, valued at $21,681,919.58. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 36,500 shares of company stock valued at $4,532,959. Insiders own 1.35% of the company’s stock.

Innospec Trading Up 0.1 %

Shares of NASDAQ IOSP opened at $125.09 on Thursday. The company has a market cap of $3.12 billion, a price-to-earnings ratio of 22.46 and a beta of 1.11. Innospec Inc. has a 12-month low of $91.74 and a 12-month high of $131.18. The stock’s 50 day simple moving average is $124.02 and its 200 day simple moving average is $117.29.

Innospec (NASDAQ:IOSPGet Free Report) last released its quarterly earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 EPS for the quarter, topping the consensus estimate of $1.59 by $0.25. The business had revenue of $494.70 million during the quarter, compared to analyst estimates of $479.47 million. Innospec had a net margin of 7.14% and a return on equity of 13.69%. The company’s quarterly revenue was down 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.20 earnings per share. As a group, equities analysts forecast that Innospec Inc. will post 6.77 earnings per share for the current fiscal year.

Innospec Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Read More

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.